ReviewFrontiers in cardiovascular medicine2019

Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease.

Aaron W Aday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.